ÇÁ·Î±×·¥
½Ã°£ | ÁÖÁ¦ | ¡¡ | ¿¬ÀÚ | ¼Ò¼Ó |
---|---|---|---|---|
08:25~08:30 | Àλ縻 | ´ëÇÑ¿Ü°úÃÊÀ½ÆÄÇÐȸ ȸÀå À±»ó¼· | ||
08:30~09:00 | Cutting edge technology of medical industry | ÁÂÀå | ¹ÚÇظ° | Â÷ÀÇ°ú´ë |
DEVICOR (Mammotome) BARD (Encore) MEDICALPARK (Bexcore) PHILIPS ÃÊÀ½ÆÄ RF Medical °íÁÖÆÄ |
||||
Session 1. Ç÷°ü | ÁÂÀå | ¹Ú¼øö ¹Ú±âÇõ |
°¡Å縯ÀÇ´ë ´ë±¸°¡Å縯ÀÇ´ë |
|
09:00~09:20 | Ultrasound imaging for EVAR | ¡¡ | Nicos Labropoulos | Stony Brook University, USA |
09:20~09:40 | Role of ultrasound in the maintenance of dialysis access | À±»óö | ¼øõÇâÀÇ´ë | |
09:40~10:00 | Differential diagnosis using ultrasound -venous malformation vs varicose vein | ±èÇâ°æ | °µ¿°æÈñÀÇ´ë | |
10:00~10:20 | How to avoid overestimation and underestimation of carotid disease | Ȳ´öºñ | °æºÏÀÇ´ë | |
10:20~10:40 | Role of ultrasound in peripheral artery intervention | ±è¼ÛÀÌ | Ãæ³²ÀÇ´ë | |
10:40~10:50 | Q&A | |||
10:50~11:00 | Coffee Break | |||
Session 2. ±¸¿¬¹ßÇ¥ | ÁÂÀå | À±»ó¼· ±èÀçÀÏ |
°¡Å縯ÀÇ´ë ÀÎÁ¦ÀÇ´ë |
|
11:00~11:10 | Artificial intelligence based prediction of radio-cephalic arteriovenous fistula maturation using preoperative ultrasound | ±èÇâ°æ | °µ¿°æÈñÀÇ´ë | |
11:10~11:20 | Ultrasonography & fluoroscopy-guided placement of chemoports via Internal jugular vein: Tips for safe and successful procedures based on a single-center experience | °í¸íÇö | Ãæ³²ÀÇ´ë | |
11:20~11:30 | Anatomical distribution of Brachial vein and Basilic vein in Koreans | ¹®±âÀ± | °¡Å縯ÀÇ´ë | |
11:30~11:40 | Ultrasonic findings after volume replacement oncoplastic breast conserving surgery using acellular dermal matrix | ÀÌÈñ½Â | °í½ÅÀÇ´ë | |
11:40~11:50 | Usefulness of cordless ultrasonic cutting energy devices in endoscopic nipple sparing mastectomy | ±ÝÈñÁ¤ | Ä¥°î°æºÏ´ëº´¿ø | |
11:50~12:00 | Development of quantification software for assessing heterogeneity in ultrasound images and its clinical application in benign thyroid nodule | ÀÓ¼ö¿µ | ȼøÀü³²´ëº´¿ø | |
12:00~12:10 | ÃÑȸ | |||
12:10~13:30 | Luncheon Symposium | ÁÂÀå | ½ÅÇõÀç | ÇѾçÀÇ´ë |
12:10~13:30 | Stereotactic vacuum assisted breast biopsy by surgeon | ¡¡ | ±è±¸»ó | °í½ÅÀÇ´ë |
Session 3. À¯¹æ & °©»ó¼± | ÁÂÀå | À±Á¤ÇÑ ±è±Çõ |
±¤ÁÖÇö´ëº´¿ø Á¶¼±ÀÇ´ë |
|
13:30~13:50 | Detection of suspicious breast microcalcifications by ultrasound and US guided percutaneous biopsy with or without wire localization | ¡¡ | Â÷°æÈ£ | ¸¾¸¶¿Ü°ú |
13:50~14:10 | Fibroepithelial tumors: pathological features and molecular mechanism | ¡¡ | ½ÅÀº¾Æ | ¿ëÀμ¼ºê¶õ½º º´¸®°ú |
14:10~14:30 | Management of unilateral axillary lymph node enlargement detected on breast ultrasound in the era of covid 19 vaccinations | ¡¡ | ÀåÁ¤¹Î | ¼¿ïÀÇ´ë ¿µ»óÀÇÇаú |
14:30~14:50 | ACR-thyroid imaging reporting and data systems and the Bethesda system for reporting thyroid cytopathology in the evaluation of thyroid nodules | ¡¡ | À±ÇöÁ¶ | ÀüºÏÀÇ´ë |
14:50~15:10 | Thyroid RFA case review: Big size benign nodules and recurrent thyroid cancers | ¡¡ | ¹éÁ¤È¯ | ¿ï»êÀÇ´ë ¿µ»óÀÇÇаú |
15:10~15:30 | °³Á¤µÈ °©»ó¼± ÃÊÀ½ÆÄ ±Þ¿©Ã¼°è ¹× ¼ö°¡Á¶Á¤¾È ¼³¸í ¹× ºÐ¼® | ¡¡ | ±èÁØÈ£ | Á¶ÀºÀ¯¿Ü°ú |
15:30~15:40 | Q&A | |||
15:40~16:00 | Coffee Break | |||
Session 4. º¹ºÎ/´ëÀåÇ×¹®/ÁßȯÀÚ | ÁÂÀå | ¹ÚÀÏ¿µ Á¶Ç×ÁÖ |
°¡Å縯ÀÇ´ë °¡Å縯ÀÇ´ë |
|
16:00~16:20 | ÃÊÀ½ÆÄ À¯µµÇÏ °£´ãÃé ¼ö¼úÀÇ ´Ù¾çÇÑ °æÇè | ¡¡ | À±°æö | ¼¿ïÀÇ´ë |
16:20~16:40 | ÈÞ´ë¿ë ÃÊÀ½ÆÄ(Handheld ultrasound)¸¦ ÀÌ¿ëÇÑ Èï¹Ì·Î¿î Áõ·Ê | ¡¡ | ¿À½Â¿µ | ¼¿ïÀÇ´ë |
16:40~17:00 | ÃÊÀ½Æĸ¦ ÀÌ¿ëÇÑ °£³» ¼Ò°áÀý Áø´ÜÀÇ ±â¼ú | ¡¡ | ±èÈ«¼ö | ¼øõÇâÀÇ´ë ¼Òȱ⳻°ú |
17:00~17:20 | ÃÊÀ½Æĸ¦ ÀÌ¿ëÇÑ »óº¹ºÎ ±Þ¼º º¹Áõ ȯÀÚÀÇ °¨º° Áø´Ü | ¡¡ | ±èÀϺÀ | ±èÀϺÀ³»°ú |
17:20~17:40 | °³¿ø°¡¿¡¼ ²À ¾Ë¾Æ¾ßÇÒ ±Ù°ñ°Ý ÃÊÀ½ÆÄÀÇ ±âÃÊ I | ¡¡ | Á¤Á¾ÇÊ | ±³ÇÏÁ¦ÀÏÀÇ¿ø |
17:40~17:50 | Q&A | |||
17:50~18:00 | Çà¿î±Ç Ãß÷ & Æóȸ»ç |
¡¡ | Room A | Room B | ||||
½Ã°£ | ÁÖÁ¦ | °»ç | ¼Ò¼Ó | ÁÖÁ¦ | °»ç | ¼Ò¼Ó |
---|---|---|---|---|---|---|
9:00~10:30 | Á÷Àå Ç×¹® ÃÊÀ½ÆÄ (5¸í) | Çѽ¸² | °¡Å縯ÀÇ´ë | Á÷Àå Ç×¹® ÃÊÀ½ÆÄ (5¸í) | À¯´Ï³ª | °¡Å縯ÀÇ´ë |
°£´ãÃé ÃÊÀ½ÆÄ (5¸í) | ±èÁöÈÆ | ±¹¸³¾Ï¼¾ÅÍ | ||||
10:30~10:50 | coffee break | |||||
10:50~12:20 | °£´ãÃé ÃÊÀ½ÆÄ (5¸í) | ÃÖÈ£Áß | °¡Å縯ÀÇ´ë | Ãæ¼öµ¹±â ÃÊÀ½ÆÄ (5¸í) | ±è´ëÇö | À̾ر賻°ú |
Áß½ÉÁ¤¸Æ°ü »ðÀÔ¼ú (5¸í) | ±è¹ÌÇü | °¡Å縯ÀÇ´ë | ¿Ü»ó ÃÊÀ½ÆÄ (5¸í) | Á¶Ç×ÁÖ | °¡Å縯ÀÇ´ë | |
12:20~13:30 | Á¡½É | |||||
13:30~14:30 | ÇÏÁöÁ¤¸Æ·ùÀÇ ÃÊÀ½ÆÄ (5¸í) | À±¿µ¿í | Ǫ¸¥¸Æ¿Ü°ú | °æµ¿¸ÆÃÊÀ½ÆÄ (5¸í) | ±èÇâ°æ | °µ¿°æÈñÀÇ´ë |
14:30~15:30 | ÇÏÁöµ¿¸ÆÀÇ ÃÊÀ½ÆÄ (5¸í) | Á¤ÇõÀç | ºÎ»êÀÇ´ë | ÇÏÁöÁ¤¸Æ·ùÀÇ ÃÊÀ½ÆÄ (5¸í) | Àü°¿õ | °¡Å縯ÀÇ´ë |
15:30~16:00 | coffee break | |||||
16:00~17:00 | À¯¹æ ÃÊÀ½ÆÄ I (5¸í) | ÀÌÀº°æ | ºñ¿¡ºñ½º³ª¹«º´¿ø | °©»ó¼± ÃÊÀ½ÆÄ I (5¸í) | Àü±â¿ø | ¹ÚÈñºØ¿Ü°ú |
À¯¹æ ÃÊÀ½ÆÄ II (5¸í) | À̵¿¼® | ºÐÈ«ºûÀ¸·Îº´¿ø | °©»ó¼± ÃÊÀ½ÆÄ II (5¸í) | È«Àç¿õ | Çöó¿ö¿©¼º¿Ü°ú | |
17:00-18:00 | VABB Mammotome (5¸í) | ½ÅÇõÀç | ÇѾçÀÇ´ë | Thyroid RFA (10¸í) | ¾öÅÂÀÍ | ÇÏÀÌÀ¯¿Ü°ú |
VABB Encore (5¸í) | ±èµ¿¿ø | ´ë¸²¼º¸ðº´¿ø | ±è¶ó¹Ì | ±è¶ó¹ÌÀ¯¿Ü°ú | ||
VABB Bexcore (5¸í) | ½Å¸¸½Ä | ¿¬¼¼À§µåÀ¯¿Ü°ú | Thyroid Core biopsy (5¸í) | °í½Â»ó | ¹ÚÈñºØ¿Ü°ú | |
Breast Core biopsy (5¸í) | ±è±¸»ó | °í½ÅÀÇ´ë | Thyroid FNA (10¸í) | À±ÇöÁ¶ | ÀüºÏÀÇ´ë | |
¹Ú¹ÎÈ£ | Àü³²ÀÇ´ë |